Cytochrome P450 3A4 Inducer
Showing 1 - 25 of >10,000
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg
Recruiting
- Drug Interactions
- CYP450 Cocktail and Transporter Substrates with Pacritinib
- +2 more
-
Austin, TexasPPD - Austin Research Unit
Jan 13, 2023
HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)
Recruiting
- HIV Infections
- VH4524184
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jan 11, 2023
Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)
Recruiting
- Antipsychotic Induced Weight Gain
- Non-alcoholic Steatohepatitis (NASH)
-
Miami, FloridaSite 01
Feb 3, 2023
Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)
Not yet recruiting
- Atopic Dermatitis
- Caffeine
- +6 more
- (no location specified)
May 26, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)
Recruiting
- Atopic Dermatitis
- Nemolizumab
- CYP 450 Substrates
-
North Hollywood, California
- +6 more
Nov 29, 2022
Healthy Volunteers Trial in Berlin (Zoliflodacin Patheon)
Recruiting
- Healthy Volunteers
- Zoliflodacin Patheon
-
Berlin, GermanyParexel Early Phase Clinical Unit
Nov 22, 2022
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)
Completed
- Drug-drug Interactions
- napabucasin
- cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
-
DeLand, FloridaAccel Research Sites
Apr 4, 2022
Healthy Trial in Salt Lake City (BMS-986165, Fluvoxamine)
Completed
- Healthy
-
Salt Lake City, UtahICON Plc (PRA Health Sciences)
Nov 9, 2021
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023
Healthy Trial in San Antonio (TD-1211, TD-1211+ itraconazole)
Completed
- Healthy
- TD-1211
- TD-1211+ itraconazole
-
San Antonio, TexasIcon Development Services
Jan 15, 2021
Crohn Disease, Ulcerative Colitis Trial in Worldwide (Ustekinumab IV Infusion, Ustekinumab SC Injection, Midazolam 2 mg)
Suspended
- Crohn Disease
- Ulcerative Colitis
- Ustekinumab IV Infusion
- +7 more
-
Cypress, California
- +15 more
Jul 21, 2022
Healthy Volunteer Trial in London (CC-99677, Methotrexate, Sulfasalazine)
Completed
- Healthy Volunteer
- CC-99677
- +8 more
-
London, United KingdomRichmond Pharmacology Limited
Aug 17, 2021
Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid
Completed
- Drug-Drug Interaction
- ITF2357 Givinostat 10mg/mL
- +4 more
-
Porto, PortugalHospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022
Healthy Adult Subjects Trial in Tempe (Omaveloxolone, Efavirenz)
Not yet recruiting
- Healthy Adult Subjects
-
Tempe, ArizonaCelerion, Inc.
Jun 16, 2023
Clindamycin-rifampin Drug Interaction in Treatment of Bone and
Completed
- Arthritis, Infectious
- Bone Diseases, Infectious
- usual antibiotic treatment
-
Paris, Ile De France, FranceGH Diaconesses Croix Saint Simon
Feb 10, 2021
COVID-19 Pneumonia Trial in Hangzhou (STI-1558, Itraconazole, Rifampin)
Not yet recruiting
- COVID-19 Pneumonia
- STI-1558
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Xiaoshan Hospital
Jan 5, 2023
Healthy Participants Trial (Darigabat, Carbamazepine)
Not yet recruiting
- Healthy Participants
- (no location specified)
Apr 11, 2023
Wilson's Disease Trial in London (900mg TETA 4HCl Once Daily Formulation, 900mg TETA 4HCl CupriorĀ®)
Not yet recruiting
- Wilson's Disease
- 900mg TETA 4HCl Once Daily Formulation
- 900mg TETA 4HCl CupriorĀ®
-
London, United KingdomRichmond Pharmacology Ltd
Nov 7, 2023